leisure time -WSS

leisure time

author：leisure time 2025-09-28 12:08:42 - browse：6

Cambridge: AbbVie — Ruby Wallau for STAT

AbbVie will pay $10 billion for the biotech firm Immunogen, the company said Thursday, acquiring an approved treatment for ovarian cancer and buying into a burgeoning area of oncology.

Under the agreement, AbbVie will pay $31.26 per share in cash for Immunogen, a nearly 100% premium to the company’s recent trading price. Central to the deal, expected to close in the middle of next year, is Elahere, an Immunogen product that won Food and Drug Administration approval for advanced ovarian cancer in 2022.

Elahere is among a surging class of cancer medicines called antibody-drug conjugates, or ADCs, which are designed to deliver a targeted dose of chemotherapy directly to tumor cells while sparing healthy tissues. AbbVie’s acquisition is the latest multibillion-dollar deal in the space, following Merck’s $22 billion agreement with ADC specialist Daiichi Sankyo and Pfizer’s $43 billion buyout of Seagen earlier this year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Senate panel clears PBM, hopsital reforms

WSS

Diversify hospital leadership teams to protect BIPOC patient health

Flint parents haunted by uncertainty, fears of lead poisoning

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Biotech incubator Curie.Bio graduates its first startup

Diversify hospital leadership teams to protect BIPOC patient health

UCSF medical school apologizes for unethical prisoner experiments

entertainment

leisure time

entertainment

Affirmative action in medical school literally saved lives

Pharma showers House GOP doctor with campaign cash

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The cancer stories no one wants to hear

23andMe had bad news about my health. I wish a person had delivered it

Diversify hospital leadership teams to protect BIPOC patient health

Supreme Court strikes down use of affirmative action

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

FDA approves potent Eli Lilly obesity drug, Zepbound

leisure time

FDA scientists endorse Pfizer/BioNTech Covid

FDA approves potent Eli Lilly obesity drug, Zepbound

Diversify hospital leadership teams to protect BIPOC patient health

FDA approves Sage Therapeutics’ rapid

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

How to ethically and practically extend health care to all

explore

leisure time

hotspot

focus